Thursday, 9 Oct 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    GEDU Group to Become Largest Foreign Education Investor in India
    GEDU Group to Become Largest Foreign Education Investor in India
    09/10/2025
    Signs of Change: Equipping Teachers with Tools for Inclusive Classrooms
    Signs of Change: Equipping Teachers with Tools for Inclusive Classrooms
    09/10/2025
    Nobel Prize 2025 in Medicine: Three Scientists Who Changed the Future of Immunology
    Nobel Prize 2025 in Medicine: Three Scientists Who Changed the Future of Immunology
    08/10/2025
    नोबेल पुरस्कार 2025 – मेडिसिन कैटेगरी में तीन वैज्ञानिकों की शानदार जीत!
    नोबेल पुरस्कार 2025 – मेडिसिन कैटेगरी में तीन वैज्ञानिकों की शानदार जीत!
    08/10/2025
    Comviva Fintech Platforms Hits  Billion Daily Transaction Milestone, Strengthening its Global Fintech Dominance
    Comviva Fintech Platforms Hits $1 Billion Daily Transaction Milestone, Strengthening its Global Fintech Dominance
    08/10/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • global
  • Business
  • june
  • announced
  • today
  •  and
  • july
  •  the
  • company
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Health

Praxis Precision Medicines to Participate in Upcoming Fireside Chat

GlobeNews Wire
Last updated: 29/08/2025 5:34 PM
GlobeNews Wire
Share
2 Min Read
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
SHARE
Praxis Precision Medicines to Participate in Upcoming Fireside Chat

BOSTON, Aug. 29, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that CEO Marcio Souza will be participating a virtual fireside chat hosted by Ritu Baral, Biotechnology Analyst, TD Cowen on September 2, 2025 at 10:00amEST to discuss content shared by Praxis at the 36th International Epilepsy Consortium (IEC).

The registration link for the fireside chat can be found here.

The overview of Praxis’ posters and presentation at the IEC event can be found here.

About Praxis  
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum™, and antisense oligonucleotide (ASO) platform, Solidus™, using our understanding of shared biological targets and circuits in the brain. Praxis has established a diversified, multimodal CNS portfolio including multiple programs across epilepsy and movement disorders, with four clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on Facebook, Instagram, LinkedIn and Twitter/X.

 
Lumina Datamatics Wins Indo-American Corporate Excellence (IACE) Award 2025 for ‘Excellence in Service (Indian Company in US)’
ICMIs Contact Center Expo 2025 Unveils Keynote Speakers
ASYAD GROUP EXECUTES HIGH-PRECISION TRANSPORT OF ULTRA-HEAVY CRYOGENIC TANK FROM INDIA TO KSA HIGHLIGHTING CROSS-BORDER LOGISTICS EXPERTISE
VdoCipher’s Piracy Detection Engine Blocks 250,000+ Video Piracy Attempts in 12 Months
RICH Miner Announces Global Expansion and Zero-Hassle Cloud Mining for Robinhood Users
TAGGED:augbiopharmaceuticalbostoncentralcharacterizedchatclinicalstagecnscompanydevelopmentdisordersexcitationinhibitionfiresidefoundgeneticglobeiecincinsightsmedicinesnasdaqNasdaq:PRAXnervousneuronalnewsnewswireparticipatepraxpraxisprecisionsystemtherapiestranslatingupcomingUS74006W1080
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program
News

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

26/07/2025
LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China
Health

LEQEMBI (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimers Disease Approved in China

29/09/2025
GEDU Group to Become Largest Foreign Education Investor in India
Automobile

AT&T Receives Frost & Sullivan’s 2025 Global Market Leadership Recognition for Passenger Vehicle Connectivity

23/09/2025
Seek Common Ground, Connect the World, the 6th Qingdao Multinationals Summit Opens Today
News

Seek Common Ground, Connect the World, the 6th Qingdao Multinationals Summit Opens Today

20/06/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?